239 related articles for article (PubMed ID: 22639083)
1. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
[No Abstract] [Full Text] [Related]
2. Gold nanorods for platinum based prodrug delivery.
Min Y; Mao C; Xu D; Wang J; Liu Y
Chem Commun (Camb); 2010 Nov; 46(44):8424-6. PubMed ID: 20936244
[TBL] [Abstract][Full Text] [Related]
3. Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance.
Song H; Li W; Qi R; Yan L; Jing X; Zheng M; Xiao H
Chem Commun (Camb); 2015 Jul; 51(57):11493-5. PubMed ID: 26094840
[TBL] [Abstract][Full Text] [Related]
4. A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.
Hou J; Shang J; Jiao C; Jiang P; Xiao H; Luo L; Liu T
Macromol Biosci; 2013 Jul; 13(7):954-65. PubMed ID: 23744619
[TBL] [Abstract][Full Text] [Related]
5. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Future Med Chem; 2012 Jul; 4(11):1380. PubMed ID: 23029699
[No Abstract] [Full Text] [Related]
6. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.
Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS
ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392
[TBL] [Abstract][Full Text] [Related]
7. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
[TBL] [Abstract][Full Text] [Related]
8. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
[TBL] [Abstract][Full Text] [Related]
9. QD-filled micelles which combine SPECT and optical imaging with light-induced activation of a platinum(IV) prodrug for anticancer applications.
Maldonado CR; Gómez-Blanco N; Jauregui-Osoro M; Brunton VG; Yate L; Mareque-Rivas JC
Chem Commun (Camb); 2013 May; 49(38):3985-7. PubMed ID: 23552819
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
Mi Y; Zhao J; Feng SS
Int J Pharm; 2012 Nov; 438(1-2):98-106. PubMed ID: 22954445
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance.
Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H
Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527
[TBL] [Abstract][Full Text] [Related]
13. Pt(IV) Prodrugs Designed to Embed in Nanotubes of a Polysaccharide for Drug Delivery.
Chen K; Cai L; Yang S; Peng S; Huang J; Xu J; Lu Z; Xu X; Fu B; Zhang L; Zhou X
ACS Appl Bio Mater; 2021 Jun; 4(6):4841-4848. PubMed ID: 35007033
[TBL] [Abstract][Full Text] [Related]
14. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?
Craig GE; Brown SD; Lamprou DA; Graham D; Wheate NJ
Inorg Chem; 2012 Mar; 51(6):3490-7. PubMed ID: 22390791
[TBL] [Abstract][Full Text] [Related]
16. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Gd
Lajous H; Riva R; Lelièvre B; Tétaud C; Avril S; Hindré F; Boury F; Jérôme C; Lecomte P; Garcion E
Biomater Sci; 2018 Aug; 6(9):2386-2409. PubMed ID: 30023990
[TBL] [Abstract][Full Text] [Related]
18. Exploring the binding of Pt drugs to gold nanoparticles for controlled passive release of cisplatin.
Comenge J; Romero FM; Sotelo C; Domínguez F; Puntes V
J Control Release; 2010 Nov; 148(1):e31-2. PubMed ID: 21529607
[No Abstract] [Full Text] [Related]
19. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
Shi H; Cheng Q; Yuan S; Ding X; Liu Y
Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
[TBL] [Abstract][Full Text] [Related]
20. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
